Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Pharmacy Benefits Management Services

Menu
Menu
Quick Links
Veterans Crisis Line Badge
My healthevet badge
 

Academic Detailing Services - Educational Materials

Navigation Menu

Introduction
Background
Types of Educational Materials
Guidance for Use of Materials

Campaigns
Attention-Deficit/Hyperactivity Disorder (ADHD)
Alcohol Use Disorder (AUD)
Benzodiazepines
Biologics/Biosimilars
Community Care
Chronic Obstructive Pulmonary Disease (COPD)
Diabetes
Dyslipidemia
Emergency Department Opioid Safety Initative (OSI)
Heart Failure (HF)
HIV PrEP
Hypertension (HTN)
Overdose Education & Naloxone Distribution (OEND)
Opioid Use Disorder (OUD)
Pain/Opioid Safety Initiative (OSI)
Pharmacogenomics (PGx)
Stimulant Use Disorder (StimUD)
SUD Harm Reduction
Suicide Prevention
Tobacco Use Disorder (TUD)
Weight Management



Background

What is Academic Detailing? | VA Academic Detailing Implementation Guide

Educational materials developed by the Pharmacy Benefits Management (PBM) Academic Detailing Services (ADS) undergo extensive review by subject matter experts (SMEs), identified topic aligned committees, and PBM Clinical Pharmacy Program Managers. All subject matter experts are required to complete conflict of interest forms.

Disclaimer: These resources are designed for use by an Academic Detailing Program. These are not instructions for the patient. Please ensure the patient speaks with their provider to determine what is in the best interest of the patient.


Return to Navigation Menu



Types of Educational Materials
  • Clinician or Provider Guide: Document utilized to guide discussion between the Academic Detailer and the clinician. This document provides visually pleasing summaries on updates of the literature and guidelines for the topic being addressed. It typically includes a combination of text, tables and graphics to illustrate information and provide support for key messages.
  • Quick Reference Guide (also known as "pocket cards"): Document containing key drug (e.g. drug dosing, monitoring) and non-drug detailed information needed to carry out key messages identified in the provider guide, such as information on side effects, dosing, lab monitoring, and interpretation of results.
  • Fact Sheet: Two page quick reference document utilized to provide additional information to support specific key messages.
  • Patient Education: Documents used to facilitate shared decision making, to engage a patient in a particular topic and encourage them to talk to their provider, or to advertise a particular treatment option or assessment tool.

Return to Navigation Menu



Guidance for External Organizations

The ADS does not provide printed materials for organizations outside of the VA. However, external organizations are welcome to print these materials themselves if they wish. Since the educational tools developed by the PBM Academic Detailing Services are in the public domain, outside entities can freely use, print, and/or link the materials on their own website. However, we request that proper credit be given to the appropriate creators.

Example of citation:
U.S. Department of Veterans Affairs, Pharmacy Benefits Management, National Academic Detailing Services. (2018). Effective Treatments for PTSD: Helping Patients Taper from Benzodiazepines (IB&P Number: IB10-910; P96798).
Retrieved from: https://www.pbm.va.gov/PBM/AcademicDetailingService/Documents/Academic_Detailing_Educational_Material_Catalog/59_PTSD_NCPTSD_Provider_Helping_Patients_Taper_BZD.pdf

If an outside entity modifies or changes the content of the VA Academic Detailing Services' educational tools, they should also indicate what the changes are and avoid using the VA logo.


Return to Navigation Menu



Attention-Deficit/Hyperactivity Disorder (ADHD)

Provider
Identification and Management of Attention-Deficit/Hyperactivity Disorder in Adults
ADHD Quick Reference Guide

Patient



Return to Navigation Menu



Alcohol Use Disorder (AUD)

Provider
Quick Reference Guide: Leading the Charge in the Treatment of AUD
Alcohol Use Disorder (AUD) Leading the Charge in the Treatment of AUD
Is Alcohol Putting Your Health at Risk?


Patient
Alcohol: How much is too much? This guide can help you make informed decisions around alcohol and your health (AUD)
Acamprosate: Recovery-Focused Treatment for Alcohol Use Disorder
Acamprosate: Using Medications to Help Manage Alcohol Use Disorder with HIV
Acamprosate Using Medications to Help Manage Alcohol Use Disorder with Hepatitis C

Baclofen: Using Medications to Help Manage Alcohol Use Disorder with HIV
Baclofen Using Medications to Help Manage Alcohol Use Disorder with Hepatitis C

Disulfiram Recovery-Focused Treatment for Alcohol Use Disorder
Disulfiram Using Medications to Help Manage Alcohol Use Disorder with HIV
Disulfiram Using Medications to Help Manage Alcohol Use Disorder with Hepatitis C
Disulfiram: Tratamiento Enfocado en Recuperación para el Trastorno por Uso de Alcohol

Gabapentin: Recovery-Focused Treatment for Alcohol Use Disorder
Gabapentin Using Medications to Help Manage Alcohol Use Disorder with HIV
Gabapentin Using Medications to Help Manage Alcohol Use Disorder with Hepatitis C

Naltrexone: Recovery-Focused Treatment for Alcohol Use Disorder
Naltrexone Using Medications to Help Manage Alcohol Use Disorder with HIV
Naltrexone Using Medications to Help Manage Alcohol Use Disorder with Hepatitis C

Topiramate: Recovery-Focused Treatment for Alcohol Use Disorder
Topiramate Using Medications to Help Manage Alcohol Use Disorder with HIV
Topiramate Using Medications to Help Manage Alcohol Use Disorder with Hepatitis C


Return to Navigation Menu



Benzodiazepines

Provider


Patient
Slowly Stopping Benzodiazepines


Return to Navigation Menu



Biologics/Biosimilars

Provider
Biologics and Biosimilar

Patient
Biosimilars Medicines


Return to Navigation Menu



Community Care

Provider

Community Care Network Provider Quick Reference


Return to Navigation Menu



Chronic Obstructive Pulmonary Disease (COPD)

Provider
COPD - A VA Clinician's Guide
Exacerbations of COPD Factsheet
Pharmacotherapy for Stable COPD
Stopping Inhaled Corticosteroids (ICS) for COPD
Living with COPD Quick Reference Guide

Patient
Living with COPD



Return to Navigation Menu





Diabetes

Provider
Hypoglycemia In Type 2 Diabetes Mellitus
Pharmacotherapy for Type 2 Diabetes Mellitus (T2DM) - A VA Clinician's Guide
Type 2 Diabetes Mellitus Diagnosis and Goal Setting

Patient



Return to Navigation Menu



Dyslipidemia

Provider

Management of Statin Intolerance


Return to Navigation Menu



Emergency Department Opioid Safety Initiative (OSI)

Provider
Emergency Department (ED): A Unique Opportunity to Save Lives Using Buprenorphine/Naloxone
Emergency Department (ED) and Buprenorphine/Naloxone Treatment


Return to Navigation Menu



Heart Failure (HF)

Provider
Managing Heart Failure in Primary Care
Managing Heart Failure in Primary Care - Quick Reference Guide

Patient
Living with Heart Failure


Return to Navigation Menu



HIV PrEP

Provider
A VA Clinician's Guide to PrEP for HIV (2023)
Pre-Exposure Prophylaxis (PrEP) for HIV Quick Guide for Clinicians

Patient
Are you PrEPared to prevent HIV?


Return to Navigation Menu



Hypertension (HTN)

Provider 
Hypertension Measurment and Documentation Fact Sheet
Hypertension Management Quick Reference Guide (QRG)
Taking the Pressure Off Hypertension Management

Patient
High Blood Pressure and Your Health: Managing the Silent Killer


Return to Navigation Menu



Overdose Education & Naloxone Distribution (OEND)

Implementation

Automated External Defibrillator (AED) Cabinet Naloxone Program: Implementation Toolkit
Equipping VA Police Services with Intranasal (IN) Naloxone: Implementation Toolkit

Provider
Prescribe Naloxone and Save a Life!  
Naloxone Formulation 2022  

Patient
Opioid Overdose Rescue With Naloxone Intramuscular Injection
   -Spanish version: Rescate de sobredosis de opioides con injeccion intramuscular de naloxona
Opioid Overdose Prevention and Reversing an Overdose with Naloxone
   -Spanish version: Prevencion de la sobredosis de opioides e inversion de una sobredosis con naloxona
My pain medicine: Am I at risk for an accidental overdose?
  -Spanish version: Mi analesico: Estoy en riesgo de sufrir una sobresdosis accidental?
Opioid Overdose Rescue with Naloxone Prefilled Syringe for Injection
Opioid Overdose Rescue with Naloxone Nasal Spray
  -Spanish version: Rescate de sobredosis de opioides con pulverizador nasal de naloxona


Please check out our OEND Page with videos.


Return to Navigation Menu



Opioid Use Disorder (OUD)

Provider

Buprenprphine for Opioid Use Disorder (OUD)
Quick Reference Guide: Identifying and Managing Opioid Use Disorder (OUD)
Identifying and Managing Opioid Use Disorder (OUD)

Patient
Do you know the truth about OUD?
Medicine Options for Opioid Use Disorder (OUD)
Buprenorphine Extended-Release Injection (Sublocade)
Naltrexone Extended-Release Injection (Vivitrol)





Return to Navigation Menu



Pain/Opioid Safety Initiative (OSI)

Provider
Opioid Deprescribing Discussion Tool
Opioid Medication Risks: Do You Know the Possible Risks from Taking Opioids?

Patient
Slowly Stopping Opioid Medications
   -Spanish version: Interrupcion linta de los opioides
Fentanyl & Carfentanil: One time could be the LAST time
   -Spanish version: Fentanilo y carfentanilo: Una vez podria ser la ULTIMA vez
Safe and Responsible Use of Opioids for Chronic Pain
Do you take both Opioids and Benzodiazepines? 
   -Spanish version:  Toma opioides y benzodiacepinas?



Return to Navigation Menu




Pharmacogenomics (PGx)

Provider
Applying Pharmacogenomic (PGx) Testing to Tacrolimus Pharmacotherapy
An Introduction to Pharmacogenomics - A VA Clinician's Guide
Applying Pharmacogenomics (PGx) Testing to Phenytoin and Fosphenytoin Pharmacotherapy
Utilizing Pharmacogenomics (PGx) Testing for Patients Undergoing Coronary Stenting
Applying Pharmacogenomics (PGx)  to Fluoropyrimidine Therapy
Applying Pharmacogenomics (PGx) to the Treatment of Major Depressive Disorder (MDD)
Applying Pharmacogenomics (PGx) Testing to Proton Pump Inhibitor (PPI) Therapy
Applying Pharmacogenomics (PGx) to Thiopurine Dosing
Pharmacogenomic (PGx) Testing & Human Leukocyte Antigen (HLA) Associated Adverse Drug Reactions
Applying PGx to Manage Statin-Associated Musculoskeletal Symptoms

Patient

Pharmacogenomic (Pgx) Testing
Pharmacogenomics (PGx) for Mental Health Medicines>



Return to Navigation Menu



Stimulant Use Disorder (StimUD)

Provider

Stimulant Use Disorder – A VA Clinician’s Guide


Return to Navigation Menu



SUD Harm Reduction

Provider

Harm Reduction & Syringe Services Programs for Safer Drug Use & Infection Prevention
Safer Injection Practices for People who Inject Drugs
Xylazine: What Clinicians Need to Know

Patient
Fentanyl & Carfentanil: One Time could be the LAST Time
Safer Injection Practices for People who Inject Drugs
Xylazine: What you need to know

Return to Navigation Menu



Suicide Prevention

Provider




Return to Navigation Menu



Tobacco Use Disorder (TUD)

Provider
A Provider's Guide to Counseling and Medication Treatment to Help Veterans with Tobacco Cessation
TUD Quick Reference Guide

Patient



Return to Navigation Menu



Weight Management

Provider




Return to Navigation Menu